Background illustration for clinical trials search

Paid Clinical Trials Austin

Discover 754 paid clinical trials in Austin, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Austin TX, San Antonio TX, Houston TX, Arlington TX,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase 2, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Austin TX, Houston TX, Dallas TX, Little Rock AR,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase 1, Phase 2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Austin TX, Houston TX, Dallas TX, New Orleans LA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase 3, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Austin TX, San Antonio TX, Lafayette LA, Germantown TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase 3, Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

for
Bladder (Urothelial, Transitional Cell) Cancer,
Location: Austin TX, Houston TX, Arlington TX, Little Rock AR,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT07480356

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Investigating the Effects of Parent Component to Cognitive Behavior Therapy (CBT) for Youth With Anxiety Disorders

for
Anxiety Disorders
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 7 - 17

Code: NCT02160444

Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

for
Neuroblastoma
Location: Austin TX, Little Rock AR, Birmingham AL, St Louis MO,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT05489887

Phase 2, Recruiting

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

for
Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent,
Location: Austin TX, Grand Rapids MI
Sponsor: Medical University of Vienna

Sex: All

Age: 0 - 19

Code: NCT01356290

Phase 2, Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

for
Neuroblastoma
Location: Austin TX, Dallas TX, Little Rock AR, St Louis MO,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT06540963

Phase 2, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Austin TX, Oklahoma City OK, Little Rock AR,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase 2, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Austin TX, San Antonio TX, Houston TX, Dallas TX,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for
Neuroblastoma
Location: Austin TX, Dallas TX, Little Rock AR, Birmingham AL,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 22

Code: NCT02559778

Phase 2, Recruiting

Beat Childhood Cancer Specimen Banking and Data Registry

for
Pediatric Cancer, Survivorship
Location: Austin TX, Little Rock AR, Kansas City MO, St Louis MO,
Sponsor: Giselle Sholler

Sex: All

Age: 0+

Code: NCT04715178

Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Austin TX, San Antonio TX, Houston TX, Fort Worth TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Austin TX, San Antonio TX, Houston TX, Dallas TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase 2, Recruiting

Quality of Pediatric Resuscitation in a Multicenter Collaborative

for
Cardiac Arrest, Cardiopulmonary Arrest
Location: Austin TX, San Antonio TX, Dallas TX, St Louis MO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT02708134

Recruiting

Virtual Reality Distraction During Pediatric Intravenous Line Placement

for
Pediatric IV Placement, Virtual Reality Distraction
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 4 - 17

Code: NCT03304769

Recruiting

Advanced SPinal Innovations With Robotics and Enabling Technology Registry

for
Spine Deformity, Idiopathic Scoliosis,
Location: Austin TX, Aurora CO, Atlanta GA, Charleston SC,
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 21

Code: NCT05071144

Recruiting

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

for
Deep Venous Thrombosis
Location: Austin TX, Dallas TX, Oklahoma City OK, Little Rock AR,
Sponsor: Yale University

Sex: All

Age: 0 - 17

Code: NCT04924322

Phase 2, Phase 3, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Austin TX, San Antonio TX, Houston TX, Fort Worth TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.

Why choose Austin for clinical trials?

Austin, Texas, provides distinct advantages for those participating in clinical trials. The city’s vibrant and diverse population offers a rich pool of participants, enhancing the accuracy and applicability of research findings. Austin is renowned for its innovative medical research environment, driven by leading institutions that focus on pioneering advancements and cutting-edge studies.

By joining a clinical trial in Austin, participants not only contribute to significant medical research but also benefit from a highly collaborative and supportive clinical research ecosystem. The city’s commitment to advancing healthcare through research ensures that participants are involved in meaningful studies that push the boundaries of medical science.

Common conditions studied in Austin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Austin